Heidi S Donovan1, Sandra E Ward2, Susan M Sereika3, Judith E Knapp3, Paula R Sherwood3, Catherine M Bender3, Robert P Edwards4, Margaret Fields5, Renee Ingel6. 1. University of Pittsburgh School of Nursing, Pittsburgh, Pennsylvania, USA. Electronic address: donovanh@pitt.edu. 2. University of Wisconsin-Madison School of Nursing, Madison, Wisconsin, USA. 3. University of Pittsburgh School of Nursing, Pittsburgh, Pennsylvania, USA. 4. School of Medicine, Pittsburgh, Pennsylvania, USA. 5. University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. 6. University of Pittsburgh School of Nursing, Pittsburgh, Pennsylvania, USA; Carlow University, Pittsburgh, Pennsylvania, USA.
Abstract
CONTEXT: Little research has focused on symptom management among women with ovarian cancer. Written Representational Intervention To Ease Symptoms (WRITE Symptoms) is an educational intervention delivered through asynchronous web-based message boards between a study participant and a nurse. OBJECTIVES: We evaluated WRITE Symptoms for 1) feasibility of conducting the study via message boards, 2) system usability, 3) participant satisfaction, and 4) initial efficacy. METHODS:Participants were 65 women (mean age, 56.5; SD = 9.23) with recurrent ovarian cancer randomized using minimization with race/ethnicity (non-Hispanic white vs. minority) as the stratification factor. Measures were obtained at baseline and two and six weeks after intervention. Outcomes were feasibility of conducting the study, system usability, participant satisfaction, and efficacy (symptom severity, distress, consequences, and controllability). RESULTS:Fifty-six (87.5%) participants were retained, and the mean usability score (range 1-7) was 6.18 (SD = 1.29). All satisfaction items were scored at 5 (of 7) or higher. There were significant between-group effects at T2 for symptom distress, with those in the WRITE Symptoms group reporting lower distress than those in the control group [t(88.4) = -2.57; P = 0.012], with a similar trend for symptom severity [t(40.4) = -1.95; P = 0.058]. Repeated measures analysis also supported a group effect, with those in the WRITE Symptoms group reporting lower symptom distress than those in the control condition [F(1, 56.7) = 4.59; P = 0.037]. CONCLUSION: Participants found the intervention and assessment system easy to use and had high levels of satisfaction. Initial efficacy was supported by decreases in symptom severity and distress.
RCT Entities:
CONTEXT: Little research has focused on symptom management among women with ovarian cancer. Written Representational Intervention To Ease Symptoms (WRITE Symptoms) is an educational intervention delivered through asynchronous web-based message boards between a study participant and a nurse. OBJECTIVES: We evaluated WRITE Symptoms for 1) feasibility of conducting the study via message boards, 2) system usability, 3) participant satisfaction, and 4) initial efficacy. METHODS:Participants were 65 women (mean age, 56.5; SD = 9.23) with recurrent ovarian cancer randomized using minimization with race/ethnicity (non-Hispanic white vs. minority) as the stratification factor. Measures were obtained at baseline and two and six weeks after intervention. Outcomes were feasibility of conducting the study, system usability, participant satisfaction, and efficacy (symptom severity, distress, consequences, and controllability). RESULTS: Fifty-six (87.5%) participants were retained, and the mean usability score (range 1-7) was 6.18 (SD = 1.29). All satisfaction items were scored at 5 (of 7) or higher. There were significant between-group effects at T2 for symptom distress, with those in the WRITE Symptoms group reporting lower distress than those in the control group [t(88.4) = -2.57; P = 0.012], with a similar trend for symptom severity [t(40.4) = -1.95; P = 0.058]. Repeated measures analysis also supported a group effect, with those in the WRITE Symptoms group reporting lower symptom distress than those in the control condition [F(1, 56.7) = 4.59; P = 0.037]. CONCLUSION:Participants found the intervention and assessment system easy to use and had high levels of satisfaction. Initial efficacy was supported by decreases in symptom severity and distress.
Authors: Sandra Ward; Heidi Donovan; Sigridur Gunnarsdottir; Ronald C Serlin; Gary R Shapiro; Susan Hughes Journal: Health Psychol Date: 2008-01 Impact factor: 4.267
Authors: Yan Leykin; Seema M Thekdi; Dianne M Shumay; Ricardo F Muñoz; Michelle Riba; Laura B Dunn Journal: Psychooncology Date: 2011-05-24 Impact factor: 3.894
Authors: Robert S Mannel; Mark F Brady; Elise C Kohn; Parviz Hanjani; Masamichi Hiura; Roger Lee; Koen Degeest; David E Cohn; Bradley J Monk; Helen Michael Journal: Gynecol Oncol Date: 2011-05-06 Impact factor: 5.482
Authors: Colin A Espie; Leanne Fleming; James Cassidy; Leslie Samuel; Lynne M Taylor; Craig A White; Neil J Douglas; Heather M Engleman; Heidi-Louise Kelly; James Paul Journal: J Clin Oncol Date: 2008-06-30 Impact factor: 44.544
Authors: Steven D Passik; Kenneth L Kirsh; Kathleen Donaghy; Elizabeth Holtsclaw; Dale Theobald; David Cella; William Breitbart Journal: J Pain Symptom Manage Date: 2002-11 Impact factor: 3.612
Authors: Alla Sikorskii; Charles W Given; Barbara Given; Sangchoon Jeon; Veronica Decker; David Decker; Victoria Champion; Ruth McCorkle Journal: J Pain Symptom Manage Date: 2007-07-09 Impact factor: 3.612
Authors: Dean J Wantland; Carmen J Portillo; William L Holzemer; Rob Slaughter; Eva M McGhee Journal: J Med Internet Res Date: 2004-11-10 Impact factor: 5.428
Authors: N Fridriksdottir; S Gunnarsdottir; S Zoëga; B Ingadottir; E J G Hafsteinsdottir Journal: Support Care Cancer Date: 2017-09-18 Impact factor: 3.603
Authors: Casey M Hay; Madeleine Courtney-Brooks; Carolyn Lefkowits; Teresa L Hagan; Robert P Edwards; Heidi S Donovan Journal: Gynecol Oncol Date: 2016-08-13 Impact factor: 5.482
Authors: Adam E Singer; Joy R Goebel; Yan S Kim; Sydney M Dy; Sangeeta C Ahluwalia; Megan Clifford; Elizabeth Dzeng; Claire E O'Hanlon; Aneesa Motala; Anne M Walling; Jaime Goldberg; Daniella Meeker; Claudia Ochotorena; Roberta Shanman; Mike Cui; Karl A Lorenz Journal: J Palliat Med Date: 2016-08-17 Impact factor: 2.947
Authors: Maureen E Lyon; Patricia A Garvie; Lawrence J D'Angelo; Ronald H Dallas; Linda Briggs; Patricia M Flynn; Ana Garcia; Yao I Cheng; Jichuan Wang Journal: Pediatrics Date: 2018-10-19 Impact factor: 7.124
Authors: Molly A McClellan; Raghav Pavan Karumur; Rachel Isaksson Vogel; Sue V Petzel; Julie Cragg; Daniel Chan; Julie A Jacko; François Sainfort; Melissa A Geller Journal: Int J Hum Comput Interact Date: 2016-01-11 Impact factor: 3.353